Fas (APO-1/CD95) is a cell surface receptor, initially identified in l
ymphoid cells, but more recently detected in the central nervous syste
m under pathologic conditions. Ligation of the fas receptor by fas lig
and or by agonist antibodies induces apoptotic cell death in most fas-
expressing cells. In the current study, using dissociated cultures of
human fetal central nervous system-derived cells, we detected fas expr
ession on astrocytes but not on neurons. Such expression differs from
our previous results using cultures of human adult central nervous sys
tem-derived cells, which demonstrated fas expression on oligodendrocyt
es but not on astrocytes; the oligodendrocytes were susceptible to cel
l death via this pathway. Using multiple assays of cell death, includi
ng nuclear propidium iodide and TUNEL staining to detect nuclear-direc
ted injury, cytofluorometric propidium iodide inclusion, and lactate d
ehydrogenase release to detect membrane-directed injury, we found that
fas ligation, however, did nor induce cell death in the cultured feta
l astrocytes. Cytokines that augmented (gamma-interferon) or inhibited
(interleukin-4) fetal astrocyte proliferation did not alter fas expre
ssion or resistance to fas ligation. Cells obtained immediately ex viv
o from human fetal but not from adult central nervous system tissue ex
pressed fas; such expression was restricted to astrocytes as assessed
by dual-stain immunohistochemistry. The fetal central nervous system c
ells did not express fas ligand. Our findings indicate that fas expres
sion on central nervous system cells may reflect their state of maturi
ty; expression may not, however, always be coupled to susceptibility t
o cell death via this pathway. (C) 1998 IBRO. Published by Elsevier Sc
ience Ltd.